J. W. Coons Advisors, LLC Gilead Sciences, Inc. Transaction History

J. W. Coons Advisors, LLC

$534 Million
Q3 2024

A detailed history of J. W. Coons Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, J. W. Coons Advisors, LLC holds 10,370 shares of GILD stock, worth $930,811. This represents 0.16% of its overall portfolio holdings.

Number of Shares

10,370

Previous 10,335 0.34%

Holding current value

$930,811

Previous $709,000 22.57%

% of portfolio

0.16%

Previous 0.13%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$66.59 - $83.99 $2,330 - $2,939	35 Added 0.34%	10,370 $869,000
Q2 2024 Jul 30, 2024	SELL	$63.15 - $72.88 $20,460 - $23,613	-324 Reduced 3.04%	10,335 $709,000
Q1 2024 May 08, 2024	SELL	$71.58 - $87.29 $33,714 - $41,113	-471 Reduced 4.23%	10,659 $780,000
Q4 2023 Feb 12, 2024	BUY	$73.27 - $83.09 $21,981 - $24,927	300 Added 2.77%	11,130 $901,000
Q3 2023 Nov 08, 2023	BUY	$73.94 - $80.67 $3,697 - $4,033	50 Added 0.46%	10,830 $811,000
Q1 2023 May 04, 2023	BUY	$77.31 - $88.08 $33,629 - $38,314	435 Added 4.2%	10,780 $894,000
Q4 2022 Feb 07, 2023	BUY	$62.32 - $89.47 $9,971 - $14,315	160 Added 1.57%	10,345 $888,000
Q3 2022 Nov 09, 2022	BUY	$59.54 - $68.01 $9,526 - $10,881	160 Added 1.6%	10,185 $628,000
Q2 2022 Aug 04, 2022	SELL	$57.72 - $65.01 $22,337 - $25,158	-387 Reduced 3.72%	10,025 $620,000
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $34,752 - $43,548	600 Added 6.11%	10,412 $621,000
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $13,949 - $15,832	-215 Reduced 2.14%	9,812 $714,000
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $26,060 - $28,116	-385 Reduced 3.7%	10,027 $702,000
Q2 2021 Jul 22, 2021	BUY	$63.47 - $69.35 $23,166 - $25,312	365 Added 3.63%	10,412 $718,000
Q1 2021 Apr 26, 2021	BUY	$60.0 - $68.46 $300 - $342	5 Added 0.05%	10,047 $648,000
Q4 2020 Feb 11, 2021	SELL	$56.65 - $64.55 $23,793 - $27,111	-420 Reduced 4.01%	10,042 $586,000
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $98,118 - $123,366	1,580 Added 17.79%	10,462 $662,000
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $121,241 - $140,784	1,676 Added 23.26%	8,882 $683,000
Q1 2020 May 06, 2020	BUY	$62.63 - $80.22 $451,311 - $578,065	7,206 New	7,206 $537,000

Others Institutions Holding GILD

# of Institutions

1,924

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of J. W. Coons Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on J. W. Coons Advisors, LLC with notifications on news.

Account

J. W. Coons Advisors, LLC Gilead Sciences, Inc. Transaction History